Sac Angiography and Glue Embolization in Emergency Endovascular Aneurysm Repair for Ruptured Abdominal Aortic Aneurysm
- First Online:
- Cite this article as:
- Koike, Y., Nishimura, J., Hase, S. et al. Cardiovasc Intervent Radiol (2015) 38: 457. doi:10.1007/s00270-014-0873-6
- 991 Downloads
The purpose of this study was to demonstrate a sac angiography technique and evaluate the feasibility of N-butyl cyanoacrylate (NBCA) embolization of the ruptured abdominal aortic aneurysm (AAA) sac in emergency endovascular aneurysm repair (EVAR) in hemodynamically unstable patients.
A retrospective case series of three patients in whom sac angiography was performed during emergency EVAR for ruptured AAA was reviewed. After stent graft deployment, angiography within the sac of aneurysm (sac angiography) was performed by manually injecting 10 ml of contrast material through a catheter to identify the presence and site of active bleeding. In two patients, sac angiography revealed active extravasation of the contrast material, and NBCA embolization with a coaxial catheter system was performed to achieve prompt sealing.
Sac angiography was successful in all three patients. In the two patients who underwent NBCA embolization for aneurysm sac bleeding, follow-up computed tomography (CT) images demonstrated the accumulation of NBCA consistent with the bleeding site in preprocedural CT images.
EVAR is associated with a potential risk of ongoing bleeding from type II or IV endoleaks into the disrupted aneurysm sac in patients with severe coagulopathy. Therefore, sac angiography and NBCA embolization during emergency EVAR may represent a possible technical improvement in the treatment of ruptured AAA in hemodynamically unstable patients.
KeywordsRuptured abdominal aortic aneurysm Endovascular aneurysm repair N-butyl cyanoacrylate
Endovascular aneurysm repair (EVAR) of ruptured abdominal aortic aneurysms (r-AAAs) is feasible and offers the potential for decreased morbidity and mortality [1, 2, 3]. There also is currently an increased recognition of abdominal compartment syndrome . Even after EVAR, ongoing bleeding from type II or IV endoleaks into the disrupted aneurysm sac in patients with severe coagulopathy may contribute to the size of the hematoma .
Sac angiography after stent-graft deployment was performed to evaluate the presence or absence of active bleeding from the aneurysm sac.
When the active bleeding continued, embolization using N-butyl cyanoacrylate was performed.
We herein introduce this technique of sac angiography in emergency EVAR and demonstrate our early experience with glue embolization during emergency EVAR in hemodynamically unstable patients with r-AAA.
Materials and Methods
Between September 2012 and October 2013, three consecutive patients (two men, one woman; mean age, 78 years; range 68–88 years) underwent sac angiography during emergency EVAR for r-AAA. All patients presented with abdominal pain and vital signs indicating hemodynamic instability. Hemodynamic instability was defined as loss of consciousness or a systolic blood pressure of <80 mm Hg despite ongoing resuscitation before induction of anesthesia. All patients were confirmed to have an r-AAA with active bleeding by contrast-enhanced computed tomography (CT). The average aneurysm diameter was 72 (range 70–75) mm, the average proximal aneurysm neck length was 24 (range 19–29) mm, and the proximal neck diameter was 21 (range 19–23) mm. Under our policy, the preferential treatment was EVAR. Open surgery was only selected as the treatment when anatomic criteria precluded effective exclusion of the aneurysm.
Characteristics of hemodynamically unstable patients with ruptured AAA in whom sac angiography was performed
Size of AAA
Diameter of proximal neck
Length of proximal neck
Extravasation in sac angiography
Amount of 50 % mixture of NBCA (ml)
Packed red cells (U)
Fresh-frozen plasma (U)
Respiratory failure, renal insufficiency
All endovascular procedures were performed in a hybrid operating room under fluoroscopy (Allura Xper FD20; Philips Medical Systems, Best, Netherlands). The procedures were started with percutaneous insertion of an aortic occlusion balloon catheter under local anesthesia as needed . The patients then underwent general anesthesia and surgical exposure of their femoral arteries with or without aortic balloon occlusion.
After confirming the position by selective angiography, embolization using a 50 % mixture of N-butyl cyanoacrylate (NBCA) (B. Braun, Melsungen, Germany) and iodized oil (Lipiodol Ultra-Fluid; Terumo) was performed (Fig. 3C). Just before the NBCA mixture was injected, the microcatheter was flushed with a 5 % glucose solution to prevent polymerization within the microcatheter. The NBCA was injected slowly into the ruptured hole through a microcatheter, and the microcatheter was immediately retracted to prevent adherence of the catheter tip to the artery wall.
Finally, balloon dilation of the proximal neck, docking zone, and iliac legs was performed for adequate sealing of the stent-graft.
Sac angiography was successfully performed in all three patients. Active bleeding from the aneurysm sac was observed in two patients (Patient 2 with Endurant and Patient 3 with Excluder), and subsequent embolization using an NBCA mixture was performed. In both cases, approximately 1 ml of a 50 % mixture of NBCA was injected. No major intraoperative complications were encountered. Completion angiography revealed no evidence of active bleeding or type I or III endoleaks. The mean procedure time was 153 (range 110–189) min with a mean total fluoroscopic time of 31 (range 26–38) min. The mean transfusion volume was 8.6 (range 4–14) units of packed red cells and 5.3 (range 4–6) units of fresh-frozen plasma.
After the procedures, major complications were reported in all three patients: respiratory failure in two and renal insufficiency in one. After a mean hospital stay of 29 (range 11–45) days, all three patients were discharged.
During the follow-up (mean 8 months; range 6–12 months), CT angiography revealed no evidence of endoleaks or stent-related problems. An accumulation of the NBCA was recognized, consistent with the bleeding site (Fig. 3D).
In this technical report, we described the methodology of sac angiography in emergency EVAR for r-AAA and NBCA embolization to occlude the bleeding site in the aneurysm sac. Follow-up CT images demonstrated an accumulation of the NBCA consistent with the bleeding site, which indicated technical success.
Although EVAR in the treatment of r-AAAs seems to be feasible [1, 2, 3], it has a potential disadvantage associated with endoleaks, which could be undesirable in cases of active bleeding. Continuous bleeding via endoleaks may exacerbate hemorrhagic shock and abdominal compartment syndrome [3, 5].
To our knowledge, there are no reports on the performance of embolization of a bleeding site to achieve rapid hemostasis in a patient with r-AAA. To reduce the risk of type II endoleaks in elective EVAR, previous reports demonstrated intrasac “thrombization” using fibrin glue injection with or without the insertion of coils [6, 7]. However, because patients with r-AAA frequently also have severe coagulation abnormalities, NBCA seems to be a more feasible embolic material [8, 9]. In addition, a previous report described successful glue embolization of an r-AAA by a late type I endoleak after EVAR . In the two cases, EVAR with NBCA embolization achieved prompt sealing with disappearance of the extravasation of contrast material as shown on the angiogram and an accumulation of NBCA as shown on the postoperative CT images. In emergent EVAR with active bleeding, we advocate that additional glue embolization is feasible.
The percentage of endoleaks after EVAR is generally reported to be 20–30 %, but endoleaks may be more common than previously believed [11, 12]. That is, completion aortography sometimes fails to detect the presence of endoleaks. Therefore, we performed sac angiography to evaluate the presence or absence of active bleeding before aortography to detect the presence of endoleak. When the active bleeding continued, following embolization would achieve prompt hemostasis.
A potential complication associated with the use of NBCA is distal ischemic injury from nontarget glue embolization . This risk can be minimized by coaxial microcatheterization of the rupture point after deployment of the stent-graft. However, this is associated with a risk of colonic or spinal cord ischemia [10, 13, 14].
In the two cases, either one or no bleeding site was demonstrated in the aneurysm sac by sac angiography. In patients with several bleeding sites in the aneurysm, embolization to fill the entire aneurysm sac may be required.
This small, retrospective series included patients who underwent sac angiography during emergency EVAR. Because patients who undergo r-AAA treatment are in severe conditions, it is difficult to demonstrate the feasibility of sac angiography and NBCA embolization of the bleeding site. Nonetheless, occlusion of the bleeding site in the aneurysm sac of the r-AAA in addition to the performance of EVAR may represent a possible technical improvement of conventional EVAR. Sac angiography would be of value as the basis for embolization of the bleeding site.
In conclusion, EVAR is associated with the potential risk of ongoing bleeding from type II or IV endoleaks into the disrupted aneurysm sac in patients with severe coagulopathy. Therefore, sac angiography and NBCA embolization during emergency EVAR may represent a possible technical improvement in the treatment of r-AAA in hemodynamically unstable patients.
Conflict of interest
The authors declare that there are no conflicts of interest.